Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.9.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.9.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.9.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.9.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDK.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDK.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
XDK.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDK.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.16.16ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.16.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KT.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KT.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KT.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KT.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LE.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LE.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LE.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LE.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.7.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.7.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.7.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.7.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.49.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.49.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.49.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.49.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.3.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.3.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.3.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.3.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-16719.1US
LB.1.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LB.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LB.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.3.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.3.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.3.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-16719.1US
GE.1.2.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GE.1.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GE.1.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GE.1.2.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.58.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.58.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used